{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/meningitis-bacterial-meningitis-meningococcal-disease/","result":{"data":{"firstChapter":{"id":"12319bd7-3980-5b0c-8deb-b4351ef52f99","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 86762336-ddd6-452a-990a-3e0976d06c41 --><h1>Meningitis - bacterial meningitis and meningococcal disease: Summary</h1><!-- end field 86762336-ddd6-452a-990a-3e0976d06c41 -->","htmlStringContent":"<!-- begin item 1ebb202d-2b5d-4233-beb0-b614a25af2f5 --><!-- begin field f628fbd3-5df8-4376-9ad5-979c4a295be7 --><ul><li>Bacterial meningitis is a life-threatening condition that can affect all ages, but is most common in babies and children.</li><li>Transmission occurs through close contact, droplets, or direct contact with respiratory secretions.</li><li>The overall annual incidence of acute bacterial meningitis in the UK is 1 per 100,000 population. </li><li>With prompt and adequate antimicrobial treatment and supportive therapy, the outcome of acute bacterial meningitis is excellent.<ul><li>The case-fatality rates for bacterial meningitis are 4–10% in children and 25% in adults. </li></ul></li><li>Complications are more common following pneumococcal meningitis and occur in about 30% of people compared with 7% with meningococcal meningitis.</li><li>Factors that affect the prognosis of bacterial meningitis include:<ul><li>Age — fatality rates are higher at extremes of age.</li><li>The causative organism.</li><li>Presence of comorbidities.</li><li>Severity at presentation.</li></ul></li><li>Clinical features of acute bacterial meningitis include:<ul><li>Non-specific symptoms: fever, nausea and vomiting, lethargy, irritable or unsettled mood, refusal of food and drink, headache, muscle ache or joint pain, and respiratory symptoms such as a cough.</li><li>More specific symptoms and signs: stiff neck, altered mental state (confusion, delirium and drowsiness, impaired consciousness), non-blanching rash, back rigidity, bulging fontanelle (in children younger than 2 years of age), photophobia, Kernig's sign, Brudzinski's sign, coma, paresis, focal neurological deficit, and seizures.</li></ul></li><li>All suspected cases of meningitis are medical emergencies requiring immediate hospital admission by telephoning 999.</li><li>For suspected meningococcal disease (meningitis with non-blanching rash or meningococcal septicaemia):<ul><li>Parenteral antibiotics (intramuscular or intravenous benzylpenicillin) should be given at the earliest opportunity, either in primary or secondary care, but this should not delay urgent transfer to hospital.</li><li>Benzylpenicillin should be withheld only in people who have a clear history of anaphylaxis after a previous dose; a history of a rash following penicillin is not a contraindication.</li></ul></li><li>For suspected bacterial meningitis without non-blanching rash:<ul><li>All people should be transferred directly to secondary care without giving parenteral antibiotics unless urgent transfer to hospital is not possible (for example, in remote locations or adverse weather conditions). If this is the case, parenteral antibiotics should be administered in primary care.</li></ul></li><li>The management of close contacts (involving prophylactic measures) should be undertaken in conjunction with the local or regional health protection unit.</li></ul><!-- end field f628fbd3-5df8-4376-9ad5-979c4a295be7 --><!-- end item 1ebb202d-2b5d-4233-beb0-b614a25af2f5 -->","topic":{"id":"5c52d7ca-c2cb-5551-ba9f-1fcdbdf1faad","topicId":"b3676823-9bef-422c-a1fe-011ca9f6883f","topicName":"Meningitis - bacterial meningitis and meningococcal disease","slug":"meningitis-bacterial-meningitis-meningococcal-disease","aliases":["Bacterial meningitis and meningococcal disease"],"chapters":[{"id":"12319bd7-3980-5b0c-8deb-b4351ef52f99","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"c72ab6e0-adbe-5cb4-9d67-4909820fb847","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"f9d67392-74e7-5adf-b712-fa42f7e69711","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"af144a12-5e1e-5d97-8d14-45db380ecef0","slug":"changes","fullItemName":"Changes"},{"id":"eb9e7802-cda3-5c04-b178-4ae4c2bb0003","slug":"update","fullItemName":"Update"}]},{"id":"9719c30a-3d48-51f7-8a76-d9a376cfc395","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"34af18fa-646e-5799-8eea-3070c9be3955","slug":"goals","fullItemName":"Goals"},{"id":"d1170912-4321-588d-88ca-217aea38c5c4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"777fba00-f0b7-56ca-aad8-482a8107aa53","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6162c8c1-72d4-5418-b083-e9261dc043af","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8b16062f-23c7-57ef-9c04-d8696d43c468","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"141459fa-eb5f-51e0-a4f1-55aa8fcf568a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"45808ab8-48c2-500e-904e-b28b1dd9f2c1","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"a71886c1-a30d-566c-84b9-d1fd02dbacd0","slug":"definition","fullItemName":"Definition"},{"id":"3bf2ba08-2574-58c3-9147-499dd2671f06","slug":"causes","fullItemName":"Causes"},{"id":"9d242c7b-d3c1-5081-8db2-1d366c43c71d","slug":"transmission","fullItemName":"Transmission"},{"id":"46f40806-a5d8-5742-ad5b-35abf21b89bb","slug":"prevalence","fullItemName":"Prevalence"},{"id":"20fadd0c-adea-5cb2-8cb7-cc9df62dd094","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6f81c33d-8bac-5747-bd44-5b3244f57b58","slug":"complications","fullItemName":"Complications"},{"id":"6e9b6946-ed39-54a6-9e90-9989f22e636b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"5bcb31df-47de-5f61-bdb9-90d4ff02c6c4","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"eeb07a78-3dda-516a-943d-8418d5224628","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5644216d-a652-51b5-a696-c9e4aac4b609","slug":"assessing-the-rash","fullItemName":"Assessing the rash"},{"id":"2fb8dc81-2176-50e5-a2c5-1bb1541cddfc","slug":"assessing-vital-signs","fullItemName":"Assessing vital signs"},{"id":"0f916e0f-ed47-5988-843a-19af47c3726d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"75dbccb7-b3c5-51dc-8069-f497798fd646","slug":"management","fullItemName":"Management","subChapters":[{"id":"1b657d07-eb89-5d3b-9404-ef623a716920","slug":"non-blanching-rash-or-meningococcal-septicaemia","fullItemName":"Scenario: Non-blanching rash or meningococcal septicaemia"},{"id":"414935f6-7030-5ea4-a397-cac8958da2c7","slug":"without-non-blanching-rash","fullItemName":"Scenario: Without non-blanching rash"},{"id":"d532e29d-6fc3-54b3-b286-b1e80ce7840c","slug":"managing-close-contacts","fullItemName":"Scenario: Managing close contacts"},{"id":"81e1e9d4-a4c9-5c10-80d9-07cc83d6dba2","slug":"follow-up-after-hospital-discharge","fullItemName":"Scenario: Follow up after hospital discharge"}]},{"id":"c620569e-fa7a-5c2c-a708-ec6432bf5c51","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"9f59f8a5-e555-56ba-861a-a492cfe5a298","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"9c42a3ff-6a45-5e6c-a247-51a81848f67a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"50077a62-1fb9-5968-a1e6-71ac64bcf7e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e85d7bc-8751-5e8f-8e77-8b91b0cf1141","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7fb74eaa-420c-5cdd-a04e-92cbd9be478c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b8d54b7e-8c9b-5d53-8a0a-6a7296727eb4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"71898679-d838-5f6d-8422-64c378e43045","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"5c52d7ca-c2cb-5551-ba9f-1fcdbdf1faad","topicId":"b3676823-9bef-422c-a1fe-011ca9f6883f","topicName":"Meningitis - bacterial meningitis and meningococcal disease","slug":"meningitis-bacterial-meningitis-meningococcal-disease","aliases":["Bacterial meningitis and meningococcal disease"],"topicSummary":"Bacterial meningitis is a life-threatening condition that can affect all ages, but is most common in babies and children.","lastRevised":"Last revised in July 2020","nextPlannedReviewBy":"2025-07-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2025-06","nextPlannedReviewByDisplay":"June 2025","specialities":[{"id":"e174a859-759f-5b1d-898e-1a4155645e13","name":"Infections and infestations","slug":"infections-infestations"},{"id":"e9e3ea2b-52b8-5242-bc9d-24052ea8647a","name":"Child health","slug":"child-health"}],"chapters":[{"id":"12319bd7-3980-5b0c-8deb-b4351ef52f99","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"c72ab6e0-adbe-5cb4-9d67-4909820fb847","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"f9d67392-74e7-5adf-b712-fa42f7e69711","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"af144a12-5e1e-5d97-8d14-45db380ecef0","slug":"changes","fullItemName":"Changes"},{"id":"eb9e7802-cda3-5c04-b178-4ae4c2bb0003","slug":"update","fullItemName":"Update"}]},{"id":"9719c30a-3d48-51f7-8a76-d9a376cfc395","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"34af18fa-646e-5799-8eea-3070c9be3955","slug":"goals","fullItemName":"Goals"},{"id":"d1170912-4321-588d-88ca-217aea38c5c4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"777fba00-f0b7-56ca-aad8-482a8107aa53","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"6162c8c1-72d4-5418-b083-e9261dc043af","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8b16062f-23c7-57ef-9c04-d8696d43c468","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"141459fa-eb5f-51e0-a4f1-55aa8fcf568a","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"45808ab8-48c2-500e-904e-b28b1dd9f2c1","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"a71886c1-a30d-566c-84b9-d1fd02dbacd0","slug":"definition","fullItemName":"Definition"},{"id":"3bf2ba08-2574-58c3-9147-499dd2671f06","slug":"causes","fullItemName":"Causes"},{"id":"9d242c7b-d3c1-5081-8db2-1d366c43c71d","slug":"transmission","fullItemName":"Transmission"},{"id":"46f40806-a5d8-5742-ad5b-35abf21b89bb","slug":"prevalence","fullItemName":"Prevalence"},{"id":"20fadd0c-adea-5cb2-8cb7-cc9df62dd094","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"6f81c33d-8bac-5747-bd44-5b3244f57b58","slug":"complications","fullItemName":"Complications"},{"id":"6e9b6946-ed39-54a6-9e90-9989f22e636b","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"5bcb31df-47de-5f61-bdb9-90d4ff02c6c4","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"eeb07a78-3dda-516a-943d-8418d5224628","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5644216d-a652-51b5-a696-c9e4aac4b609","slug":"assessing-the-rash","fullItemName":"Assessing the rash"},{"id":"2fb8dc81-2176-50e5-a2c5-1bb1541cddfc","slug":"assessing-vital-signs","fullItemName":"Assessing vital signs"},{"id":"0f916e0f-ed47-5988-843a-19af47c3726d","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"75dbccb7-b3c5-51dc-8069-f497798fd646","slug":"management","fullItemName":"Management","subChapters":[{"id":"1b657d07-eb89-5d3b-9404-ef623a716920","slug":"non-blanching-rash-or-meningococcal-septicaemia","fullItemName":"Scenario: Non-blanching rash or meningococcal septicaemia"},{"id":"414935f6-7030-5ea4-a397-cac8958da2c7","slug":"without-non-blanching-rash","fullItemName":"Scenario: Without non-blanching rash"},{"id":"d532e29d-6fc3-54b3-b286-b1e80ce7840c","slug":"managing-close-contacts","fullItemName":"Scenario: Managing close contacts"},{"id":"81e1e9d4-a4c9-5c10-80d9-07cc83d6dba2","slug":"follow-up-after-hospital-discharge","fullItemName":"Scenario: Follow up after hospital discharge"}]},{"id":"c620569e-fa7a-5c2c-a708-ec6432bf5c51","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"9f59f8a5-e555-56ba-861a-a492cfe5a298","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"9c42a3ff-6a45-5e6c-a247-51a81848f67a","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"50077a62-1fb9-5968-a1e6-71ac64bcf7e1","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7e85d7bc-8751-5e8f-8e77-8b91b0cf1141","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"7fb74eaa-420c-5cdd-a04e-92cbd9be478c","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b8d54b7e-8c9b-5d53-8a0a-6a7296727eb4","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"71898679-d838-5f6d-8422-64c378e43045","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"5c52d7ca-c2cb-5551-ba9f-1fcdbdf1faad"}},"staticQueryHashes":["3666801979"]}